---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-23-001594"
form_type: "8-K"
ticker: "UFPT"
cik: "0000914156"
company_name: "UFP TECHNOLOGIES INC"
filed_at: "2023-03-10T23:59:59+00:00"
generated_at: "2026-06-18T06:11:36.629633+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# UFP Technologies reports record 2022 revenue $353.8M, EPS $5.45 (+160% YoY)

## Summary
- Full-year 2022 revenue $353.8M (+71.5% YoY); net income $41.8M ($5.45 diluted EPS) vs $15.9M ($2.09) in 2021.
- Q4 2022 revenue $91.2M (+61.9% YoY); net income $8.5M ($1.10 diluted EPS) vs $3.2M ($0.42) in Q4 2021.
- Medical market sales grew 116% to $286.2M for the year; acquisitions (DAS, Contech, Advant Medical) performed above expectations.
- Organic base business grew 18.6% in 2022; adjusted operating income $44.5M vs $21.6M in 2021.
- Ended year with ~$55M debt; management bullish on synergies and new investments.

## SEC filing metadata
- accession: 0001171843-23-001594
- form_type: 8-K
- ticker: UFPT
- cik: 0000914156
- company_name: UFP TECHNOLOGIES INC
- filed_at: 2023-03-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/914156/000117184323001594/0001171843-23-001594-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/914156/000117184323001594/f8k_031023.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-23-001594
- JSON: https://secwatch.observer/filing/0001171843-23-001594.json
- Plain text: https://secwatch.observer/filing/0001171843-23-001594.txt

## Key facts
- Earnings Releases
  UFP TECHNOLOGIES INC reported its fourth quarter ended December 31, 2022 results: revenue $91.2 million, net income $8.5 million, EPS $1.10 per diluted common share.
  - Period: its fourth quarter ended December 31, 2022
  - Revenue: $91.2 million
  - Net income: $8.5 million
  - EPS: $1.10 per diluted common share
  - Result: reported results
  source text: For its fourth quarter ended December 31, 2022, the Company reported net income of $8.5 million or $1.10 per diluted common share outstanding, compared to $3.2 million or $0.42 per diluted common share outstanding in the same period of 2021. Sales for the fourth quarter 2022 were $91.2 million versus 2021 fourth quarter sales of $56.3 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/914156/000117184323001594/0001171843-23-001594-index.htm
- Earnings Releases
  UFP TECHNOLOGIES INC reported its year ended December 31, 2022 results: revenue $353.8 million, net income $41.8 million, EPS $5.45 per diluted common share.
  - Period: its year ended December 31, 2022
  - Revenue: $353.8 million
  - Net income: $41.8 million
  - EPS: $5.45 per diluted common share
  - Result: reported results
  source text: UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of engineered solutions primarily for the medical market, today reported net income of $41.8 million or $5.45 per diluted common share outstanding for its year ended December 31, 2022, compared to net income of $15.9 million or $2.09 per diluted common share outstanding for 2021. Net Sales for 2022 were $353.8 million compared to 2021 sales of $206.3 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/914156/000117184323001594/0001171843-23-001594-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.